Zacks Investment Management »

Mirum Pharmaceuticals shares owned by Zacks Investment Management

Quarter-by-quarter ownership of Mirum Pharmaceuticals (MIRM) shares owned by Zacks Investment Management from 13F filings

Historical chart of Zacks Investment Management investment in Mirum Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Mirum Pharmaceuticals held by Zacks Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Mirum Pharmaceuticals by Zacks Investment Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $3.4M 37k 92.38
2025-12-31 $2.4M 30k 78.99

More positions owned by Zacks Investment Management

NVIDIA Corporation (NVDA)
Apple (AAPL)
Alphabet Cap Stk Cl A (GOOGL)
Microsoft Corporation (MSFT)
Caterpillar (CAT)
JPMorgan Chase & Co. (JPM)
Wal-Mart Stores (WMT)
Exxon Mobil Corporation (XOM)
Broadcom (AVGO)
Meta Platforms Cl A (META)
Amazon (AMZN)
Johnson & Johnson (JNJ)
Parker-Hannifin Corporation (PH)
Cisco Systems (CSCO)
Abbvie (ABBV)

View all positions for Zacks Investment Management

Top funds holding Mirum Pharmaceuticals

Frazier Life Sciences Management
Henderson Group
BlackRock
Vanguard Group
Vanguard Capital Management
State Street Corporation
Eventide Asset Management
BVF
Vanguard Portfolio Management
Novo A/S
Geode Capital Management
Wellington Management Company
Tang Capital Management
Citadel Advisors
TCG Crossover Management

View all funds holding Mirum Pharmaceuticals